Evidence map›Paper›PMID 34976803›Full record

ArticleFrontiers in oncology2021

Case Report: Vasculitis Triggered by SIRT in a Patient With Previously Untreated Cholangiocarcinoma.

Antonia Stamatiou, Jeremy Jankovic, Petr Szturz, Francois Fasquelle, Rafael Duran, Niklaus Schaefer, Antonella Diciolla, Antonia Digklia

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Antonia StamatiouDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Jeremy JankovicDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Petr SzturzDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Francois FasquelleUniversity Institute of Pathology, Clinical Pathology Service, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Rafael DuranDepartment of Diagnostic Radiology and Interventional Radiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Niklaus SchaeferFaculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Antonella DiciollaDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Antonia DigkliaDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
University of Lausanne · CHUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arising from the biliary tract, cholangiocarcinoma is a rare and aggressive epithelial cancer. According to the primary site, it can be further classified into intrahepatic, perihilar and distal types. Due to the lack of symptoms early in the disease course, most patients are diagnosed at advanced stages. Being not candidates for curative surgical management, these patients are treated with palliative systemic chemotherapy, and their prognosis remains poor. Using radioisotopes like yttrium-90 -labeled microspheres (

Indexed as

cancercase reportcholangiocarcinomaradioembolizationSIRTvasculitis

Identifiers

PMID34976803
PMCPMC8716376
OpenAlexW4200340825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.